Skip to content

Glue for Cancer Patients: Suyuan Chen Wins Merck Innovation Cup 2021

Dortmund, 24th August 2021

Suyuan Chen, a doctoral student in the Proteomics working group, won the Merck Innovation Cup 2021 with his "Drug Discovery Technologies" team. Together with six other junior scientists from Israel, Canada, London and Munich, he has worked out a plan on how molecular glue can be created and used even better in cancer treatment in the future.

These small molecules stabilise an interplay between proteins that normally hardly interact. In this way, researchers can "glue" disease-causing proteins to others, which the body then destroys. The doctoral students and postdocs from the disciplines of biochemistry, (structural) biology, chemical proteomics and medicinal and organic chemistry are not allowed to talk publicly about the details of their idea.  Merck has taken up the winning idea in order to pursue it further within the Group. "I am not only happy about the win, but especially that our idea could help advance drug development for cancer therapies," says Chen.

Every year, young researchers can apply for a place at the summer camp and competition of the German science and technology company Merck KGaA. After a two-phase selection process in June 2021, based on CV and project ideas, the applicants were divided into six teams: Oncology, Immuno-Oncology, Immunology, Drug Discovery Technologies, Digitalisation and Pandemic Threat. Over the course of a week at the end of June, the teams not only had to develop their ideas but also prepare and present a complete business plan. For Chen and his teammates, the intensive work in the short time was worth it: the team won first place and 20,000 euros, which they can use at their personal leisure.

Change of perspective & more than just a competition

The "Innovation Cup Summer Camp" - which took place online due to the pandemic - offered participants more than just a competition. In lectures and discussion rounds, experts gave them the technical and economic perspective of a company on new research ideas. In addition, the young scientists learned how to successfully present projects to a corporate management. "It's very exciting to learn how the industry thinks and what the business side looks like for them," Chen concludes. Apart from the change of perspective, he especially liked the opportunity to meet so many like-minded people from all over the world: "In such a diverse group, you learn a lot about teamwork and how to deal with criticism." In the future, the 30-year-old would like to keep in touch with his fellow participants through the alumni group and expand his network to include new international partners and friendships. The winners want to use the prize money to finally meet in person as soon as the pandemic allows.

(Cheyenne Peters)

Suyuan Chen presents his Merck Innovation Cup.

Suyuan Chen presents his Merck Innovation Cup.

© ISAS

Share

Further articles

Laboratory Meets Clinic: Understanding Heart Function with Stem Cells

How can new therapeutic approaches for heart failure be developed more effectively? Stem cell research plays a central role in the HI-FIVE project. In this interview, PD Dr Anna Klinke (Herz- und Diabeteszentrum NRW) talks about her work between the lab and the clinic. She explains how the versatility of stem cells enables heart and vascular cells to be obtained from individual patients' blood and why this is an important step in investigating the specific effects of new active substances.

What are you doing at ISAS, Kevin?

What changes take place in heart muscle cells when a left ventricular assist device is used? ISAS doctoral student Kevin Hau (28) is tackling this question by researching the consequences of heart attacks using various omics analyses.

Kevin Hau is wearing a white coat bearing the ISAS logo. He is standing next to a microscope in a laboratory. In the lower left corner of the image, a computer screen can be seen. Open on the monitor is a microscopic image of reddish tissue.

Copenhagen: Different Molecules, New Perspectives?

Felix Hormann is spending three months conducting research at the University of Copenhagen. In this interview, the ISAS doctoral student discusses the new perspective he has gained on his lipid research and his exciting day-to-day life as a scientist in Denmark.

Felix Hormann is standing at a crossroads. In the background, there is a traffic sign with writing in Danish.

New Perspectives for Heart Failure Therapy

How are new therapeutic approaches being developed to close the gap in the treatment of patients with heart failure? And what knowledge from clinical practice is crucial for this? Prof. Dr Tanja Rudolph provides insights into her daily work as a cardiologist and talks about her role in the translational research project HI-FIVE, and the future of cardiovascular disease therapy.

PODCAST »NACHGEFORSCHT – DIE LIVESCHALTE INS LABOR« Episode 12: Less Is More, at Least When It Comes to the Number of Cells

PhD student Susmita Ghosh talks about her research on neutrophil granulocytes – tiny immune cells that play a role in both defending the body against infections and inflammatory processes. Instead of working with countless cells, the biologist optimises analytical methods to enable meaningful proteome analyses with an extremely small number of cells. Ghosh explains why ‘less is more’ and what this has to do with modern mass spectrometry in episode 12 of the podcast.

What are you doing at ISAS, Nora?

Nora Pauly is writing her doctoral thesis on the consequences of heart attacks at the joint graduate college of Essen University Hospital and ISAS. With the bed-to-bench-to-bed principle, her work in basic research is closely linked to the everyday clinical practice of caring for heart attack patients.

New Framework for Efficient Image Data Analysis in Biomedicine

How can AI be used optimally in bioimaging research? A team of international researchers and scientists led by Dr Jianxu Chen from ISAS has developed a framework designed to make it easier for biomedical scientists to work with data-centric AI. Using the example of vascular segmentation, the authors of the publication in the journal npj imaging now demonstrate the advantages of the new framework.

3 Questions for Susmita Ghosh

How does gut microbiota affect the immune system? Susmita Ghosh conducts research on proteins and immune cells at ISAS. In this interview, the biologist talks about her work and explains how gut flora and the immune system could affect the outcomes of a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.